| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |